Fluorescent cancer cells to guide brain surgeons

Apr 03, 2009

Gliomas are malignant brain tumors that arise from glial (supporting) cells of the brain. Gliomas are often resistant to chemotherapy. These tumors grow fine extensions that infiltrate normal brain tissue and, in addition, individual tumor cells can form satellites in surrounding tissue. Therefore, it is almost impossible to remove the tumor tissue completely by surgery.

Yet, radical surgical removal of the would substantially improve the prognosis of patients. Surgeons are confronted with the difficulty of discriminating between tumor tissue and healthy during surgery. Dr. Eva Frei of DKFZ, collaborating with doctors and researchers of the Medical Faculty of Heidelberg University, has now developed a method to improve neurosurgery.

The scientists took advantage of the fact that tumors cover their increased energy needs, among other things, by taking up large amounts of the blood protein albumin. The researchers attached a fluorescent substance (5-aminofluorescein) to albumin, which is distributed throughout the body via the and eventually accumulates in the brain tumor. Laser light causes the substance to glow and makes the fine extensions of the tumor visible.

"Other contrast agents often fade," says Dr. Eva Frei, "for tumor resection can take five to six hours." The fluorescence marker attached to albumin, however, is visible during the entire operation.

The scientists tested the albumin method in thirteen patients with malignant gliomas. In nine cases it was possible to remove the fluorescent tumor tissue completely thanks to the intensive yellow-green light signal. The researchers calculated that the probability of the glowing tissue being tumor cells is 97 percent.

"Staining is a tremendous help for the surgeon, because he or she can recognize the exact borders between tumor and normal brain tissue, which is normally very difficult," explains Eva Frei. "Another problem is that the tumor often exerts pressure on the meninx so that, when it is opened for surgery, the tumor shifts or changes its shape." The new method takes account of this 'brain shift' effect and makes the effort of intraoperative MRTs unnecessary. Further advantages of the new method are that it is tolerable, inexpensive and easy to apply.

Tolerability and effectiveness of the staining method will be validated next year in a larger study involving several hospitals. The scientists will monitor in a long-term study whether the prognosis of patients will improve as a result of the new method.

More information: Paul Kremer, Mahmoudreza Fardanesh, Reinhard Ding, Maria Pritsch, Saida Zoubaa and Eva Frei: Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin. Neurosurgery 2009, DOI:10.1227/01.NEU.0000335787.17029.67.

Source: Helmholtz Association of German Research Centres

Explore further: Endogenous hormones improve breast cancer risk models

add to favorites email to friend print save as pdf

Related Stories

'Gateway' gene discovered for brain cancer

Feb 14, 2007

Researchers have discovered that the same genetic regulator that triggers growth of stem cells during brain development also plays a central role in the development of the lethal brain cancer malignant glioma. In experiments ...

Tumor-killing virus selectively targets diseased brain cells

Feb 19, 2008

New findings show that a specialized virus with the ability to reproduce its tumor-killing genes can selectively target tumors in the brains of mice and eliminate them. Healthy brain tissue remained virtually untouched, according ...

Recommended for you

Endogenous hormones improve breast cancer risk models

15 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

16 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
1 / 5 (1) Apr 04, 2009
Please try COOLING the brain!!! Mitosis slows at lower temperature! Even a modified cyroablation at your level of expertise is well worth consideration!